A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 59-66

  Zhao, Xiaoyan ^a,d   Bu, De xiu ^b   Hayfron, Kweku ^a,e   Pinkerton, Kent E ^a   Bevins, Charles L ^c   Lichtman, Andrew ^b   Wiedeman, Jean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Apoptosis; Atherosclerosis; Chlamydia pneumoniae; Secondhand smoke

Indexed keywords

ALPHA ACTIN; APOLIPOPROTEIN E; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD134 ANTIGEN; CD4 ANTIGEN; COMPLEMENT COMPONENT C1Q; FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HEAT SHOCK PROTEIN 60; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CHLAMYDIAL PNEUMONIA; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; DOWN REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE SMOKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; IN SITU NICK-END LABELING; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PHAGOCYTOSIS; TOBACCO SMOKE POLLUTION; TUMOR NECROSIS FACTORS;

EID: 84862823304     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.005     Document Type: Article

References (29)

1. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. U.S. Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
2. Kuo C., Campbell L.A. Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis 2000, 181(Suppl. 3):S432-S436.
3. Wiedeman J.A., Kaul R., Heuer L.S., et al. Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells. Microb Pathog 2005, 39:197-204.
4. Naiki Y., Sorrentino R., Wong M.H., et al. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol 2008, 181:7176-7185.
5. Doz E., Noulin N., Boichot E., et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 2008, 180:1169-1178.
6. Shimada K., Chen S., Dempsey P.W., et al. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog 2009, 5:e1000379.
7. Yan Z.Q., Hansson G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007, 219:187-203.
8. Mallett S., Fossum S., Barclay A.N. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO J 1990, 9:1063-1068.
9. Wang X., Ria M., Kelmenson P.M., et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005, 37:365-372.
10. Thorp E.B. Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease. Apoptosis 2010, 15:1124-1136.
11. Ishimoto Y., Ohashi K., Mizuno K., et al. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem 2000, 127:411-417.
12. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010, 10:36-46.
13. Thorp E., Cui D., Schrijvers D.M., et al. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of ApoE-/- mice. Arterioscler Thromb Vasc Biol 2008, 28:1421-1428.
14. Bhatia V.K., Yun S., Leung V., et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 2007, 170:416-426.
15. Boisvert W.A., Rose D.M., Boullier A., et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 2006, 26:563-569.
16. Aprahamian T., Rifkin I., Bonegio R., et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004, 199:1121-1131.
17. Yang Z., Knight C.A., Mamerow M.M., et al. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in Apolipoprotein E-/- mice fed a chow diet. Circulation 2004, 110:3715-3720.
18. Hodzic E., Feng S., Fish D., et al. Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. J Infect Dis 2001, 183:1781-1786.
19. Gotsman I., Grabie N., Dacosta R., et al. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 2007, 117:2974-2982.
20. Bu D.X., Tarrio M., Maganto-Garcia E., et al. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol 2011, 31:1100-1107.
21. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
22. Barnoya J., Glantz S.A. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111:2684-2698.
23. Vardavas C.I., Panagiotakos D.B. The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence. Inflamm Allergy Drug Targets 2009, 8:328-333.
24. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008, 79:360-376.
25. Song L., Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 2004, 177:43-51.
26. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2:372-377.
27. Murata K., Ishii N., Takano H., et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 2000, 191:365-374.
28. Ohshima Y., Tanaka Y., Tozawa H., et al. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997, 159:3838-3848.
29. Rogers P.R., Song J., Gramaglia I., et al. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001, 15:445-455.